Email updates

Keep up to date with the latest news and content from Journal of Medical Case Reports and BioMed Central.

Open Access Highly Accessed Case report

Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports

David Farhi1, Paul Duriez2, Selim Aractingi1, Jacques Cosnes3 and Kiarash Khosrotehrani1*

Author Affiliations

1 AP-HP, Hôpital Tenon, Department of Dermatology, Paris F-75020, France

2 AP-HP, Hôpital Saint Antoine, Department of Pathology, Paris F-75012, France

3 AP-HP, Hôpital Saint Antoine, Department of Gastroenterology, Paris F-75012, France

For all author emails, please log on.

Journal of Medical Case Reports 2007, 1:109  doi:10.1186/1752-1947-1-109

Published: 3 October 2007

Abstract

Background

Extraintestinal manifestations of Crohn's disease may involve the skin, the eyes, the genital mucosa, and the joints. Dermatoses associated with Crohn's disease include neutrophilic dermatoses, erythema nodosum, granulomatous dermatitis, blistering dermatoses, and non-specific skin manifestations. Cutaneous Crohn's disease is characterized by skin non-caseating epithelioid granulomatas with giant cells, remote from the gastrointestinal tract. We report herein two new cases.

Observations

On both patients, differential diagnosis of neutrophilic dermatoses and infectious disease were evoked, and antimicrobial agents were introduced in one of them. Given the atypical presentation, the final diagnosis of cutaneous Crohn's disease could only be made with histological examination. In patient 1, the plaques decreased in size and infiltration by more than 75% after 3 weeks of treatment with bethametasone dipropionate 0.05% cream. In patient 2, the plaques decreased by more than 50% after 6 weeks of treatment with prednisolone (45 mg/day) and azathioprine (100 mg/day).

Discussion

Cutaneous Crohn's disease may present as dusky, erythematous, infiltrated, and ulcerated plaques and nodules. Female-to-male sex ratio is about 2, and the mean age at onset is 35. Recurrently, the hypothesis of a skin mycobacterial or fungal infection greatly delays proper treatment. Rarity of cutaneous Crohn's disease hampers therapeutic assessment in controlled trials. Thus, available literature is limited to case reports and sparse small series, with contradictory results. These reports are subject to publication bias, and no definite evidence-based recommendations can be made on the most adequate therapeutic strategy.